“Omalizumab: new addition to dermatologic therapy for chronic spontaneous/idiopathic urticaria”, J Pak Assoc Dermatol, vol. 25, no. 4, pp. 249–251, Nov. 2016, doi: 10.66344/jpad.v25i4.139.